Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Researchers reported that a single-dose therapeutic interfering particle (TIP) lowers SARS-CoV-2 pathogenesis and shedding among hamsters.

What Happens When You Catch More than One Virus?

Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection

COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy

Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment, Microbial Cell Factories

COVID-19—from mucosal immunology to IBD patients - Mucosal Immunology

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19

SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis

Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D1CS01170G

SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities

Coronavirus biology and replication: implications for SARS-CoV-2

Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target